Metformin Had Potential to Increase Endocan Levels in STZ-Induced Diabetic Mice
Background: Type 2 diabetes mellitus is a chronic metabolic disorder with prominent vascular injuries. In this condition, the levels of multiple pro- and anti-angiogenic factors have been shown to change. This study aimed to investigate the possible effect of metformin on pro-angiogenic factor, endo...
Saved in:
Main Authors: | Elmira Zolali (Author), Sevda Shayesteh (Author), Reza Rahbarghazi (Author), Haleh Vaez (Author), Hamid Reza Heidari (Author), Alireza Garjani (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
by: Haleh Vaez, et al.
Published: (2023) -
Comparison of Natural Honey and Metformin on Pancreatic Histopathology in STZ- Induced Diabetic Rats
by: Ozra Nasrolahi, et al.
Published: (2014) -
Immunohistochemical Expression of Endocan in Ameloblastoma
by: Salam N. Jawad, et al.
Published: (2016) -
Are Endocan Plasma Levels Altered in Preeclampsia?
by: Ana Cristina dos Santos Lopes, et al.
Published: (2021) -
Metformin and Gegen Qinlian Decoction boost islet α-cell proliferation of the STZ induced diabetic rats
by: Li Xu, et al.
Published: (2022)